Evidence map›Paper›PMID 21595827›Full record

ReviewThe FEBS journal2011

Understanding the complex mechanisms of β2-microglobulin amyloid assembly.

Timo Eichner, Sheena E Radford

Abstract readReview
In one paragraph

Review in The FEBS journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Article
  2. Review
  3. βNature neuroscience · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Stress Response Is the Main Trigger of Sporadic Amyloidoses.International journal of molecular sciences · 2021
    Review
  9. Article
  10. The role of the IThe Journal of biological chemistry · 2020
    Article
  11. Review
  12. Article
  13. Collagen I Weakly Interacts with the β-Sheets of βJournal of the American Chemical Society · 2020
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Timo EichnerDepartment of Biochemistry, Brandeis University, Waltham, MA 02454, USA. teichner@brandeis.edu
Sheena E Radford

Funding

Wellcome Trust 062164Wellcome Trust 075675Wellcome Trust GR075675MA
6 · The paper itself

Abstract

Several protein misfolding diseases are associated with the conversion of native proteins into ordered protein aggregates known as amyloid. Studies of amyloid assemblies have indicated that non-native proteins are responsible for initiating aggregation in vitro and in vivo. Despite the importance of these species for understanding amyloid disease, the structural and dynamic features of amyloidogenic intermediates and the molecular details of how they aggregate remain elusive. This review focuses on recent advances in developing a molecular description of the folding and aggregation mechanisms of the human amyloidogenic protein β(2)-microglobulin under physiologically relevant conditions. In particular, the structural and dynamic properties of the non-native folding intermediate I(T) and its role in the initiation of fibrillation and the development of dialysis-related amyloidosis are discussed.

Indexed as

Amyloidbeta 2-MicroglobulinAmyloidosisHumansProtein FoldingAmyloidbeta 2-Microglobulin

Identifiers

PMID21595827
PMCPMC3229708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.